Another GLP-1 drug is up for Medicare negotiations under the Inflation Reduction Act.

Eli Lilly’s diabetes drug Trulicity is among 15 drugs selected for the third round of negotiations. For the first time, CMS has …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registeration number 16808844